The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s41199-016-0009-6
Published Online: 2016-08-10
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Tinhofer, Ingeborg
Budach, Volker
Jöhrens, Korinna
Keilholz, Ulrich